Skip secondary menu

NINDS Advisory Council Meeting Agenda - September 17-18, 2009


Department of Health and Human Services
National Institutes of Health
National Institute of Neurological Disorders and Stroke

National Advisory Neurological Disorders and Stroke Council
176th Meeting
September 17-18, 2009
Building 31, C Wing, 6th Floor, Conference Room 10
31 Center Drive
Bethesda, Maryland 20892
Contact Number at Meeting (301) 402-8710

Council Subcommittee Meetings:

September 16, 2009
Clinical Trials Subcommittee
Hyatt Regency Bethesda, Bethesda, Maryland
6:00 p.m. to 8:00 p.m.- Closed Session

September 17, 2009
Clinical Trials Subcommittee
Building 31, C Wing, Conference Room 10, Bethesda, Maryland
8:00 a.m. to 10:00 a.m.- Open Session

September 17, 2009
Basic and Preclinical Programs Subcommittee
Building 31, C Wing, Conference Room 7, Bethesda, Maryland
8:00 a.m. to 10:00 a.m.-Open Session

Advisory Council Meeting:

Open Session - September 17, 2009
10:30 a.m.
I. Call to Order and Opening Remarks  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Dr. Story Landis
                                                                                                                              Chairperson

10:35 a.m.
II. Report of the Associate Director for Extramural Research, NINDS . . . . . . . Dr. Robert Finkelstein
                                                                                                        Council Executive Secretary

    A.   Consideration of Minutes of May 28-29, 2009, Meeting
    B.   Confirmation of Dates for Future Council Meetings
                                    February 4-5, 2010               (Thursday and Friday) 
                                    May 27-28, 2010                  (Thursday and Friday)
                                    September 23-24, 2010         (Thursday and Friday)
                                    February 3-4, 2011               (Thursday and Friday)
                                    May 26-27, 2011                  (Thursday and Friday)
                                    September 15-16, 2011         (Thursday and Friday)
    C.   Other Items
               Expedited Review Process
               Loan Repayment Program
               DER Announcements

10:45 a.m.
III. Report of the Director, NINDS . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .  Dr. Story Landis

11:45 a.m. - Lunch

1:00 p.m.
IV. Concept Clearance for FY 2010 Proposed Initiatives . . . . . . . . . . . . . . . . . . . . . Dr. Finkelstein

1:30 p.m.
V. Update on the American Recovery and Reinvestment Act . . . . . . . . . Drs. Landis and Finkelstein

2:15 p.m. - Break

2:30 p.m.
VI. NIH Public-Private Partnerships
            The Alzheimer's Disease Neuroimaging Initiative (ADNI): A Model for Public-Private
             Partnership in Neuroscience . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Dr. Richard Hodes
                                                                                               Director, National Institute on Aging


            Public-Private Partnerships with Rare Disease Communities . . . . . . . . . . . . . .Dr. Dan Tagle
                                                                                                                         Program Director
                                                                                                      Neurogenetics Cluster, NINDS


            Pharmacologic Bioequivalence between Generic and Brand Name Antiepileptic Drugs
            in Patients with Epilepsy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Dr. Brandy Fureman
                                                                                                                         Program Director
                                                                              Channels, Synapses & Circuits Cluster, NINDS


            PPPs--Dos and Don'ts for Engaging Outside Partners . . . . . . . . . . . . Dr. Barbara Mittleman
                                                                            Director, Program on Public-Private Partnerships
                                                                        Office of Science Policy, Office of the Director, NIH

4:00 p.m.
VII. Council Subcommittee Reports

            Clinical Trials Subcommittee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Dr. Laura Ment
                                                                                                                 NANDS Council Member

            Basic and Preclinical Programs Subcommittee . . . . . . . . . . . . . . . . . . . . Dr. John Povlishock
                                                                                                                 NANDS Council Member

4:30 p.m.* *
Adjournment - September 17, 2009

8:00 a.m.
Closed Portion - September 18, 2009

*This portion of the meeting is being closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S. Code and Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

VIII. Review of Conflict of Interest, Confidentiality, and Council Procedures
     Council Consideration of Pending Applications . . . . . . . . . . . . . . . . . . . . . . . Dr. Robert Finkelstein

11:30 a.m.**
Adjournment
**These times are tentative

Last updated January 6, 2011